AGM VideoTORONTO, ON / ACCESSWIRE / October 8, 2015 / Theralase Technologies Inc. ("Theralase" or the "Company")(TLT.V) (TLTFF), a leading biotechnology manufacturer focused on commercializing medical technologies to eliminate pain and destroy cancer, announced today that it has released the video presentations conducted at the end of its Annual General and Special Meeting held on October 2, 2015 in Toronto, Canada.
The presentations were delivered by Roger Dumoulin-White, President and CEO of Theralase, Dr. Lothar Lilge, Senior Scientist, Princess Margaret Cancer Center, University Health Network ("UHN") and Dr. Girish Kulkarni, Uro-Oncologist, also from UHN.
The videos of the presentation may be viewed at:
AGM 2014 - Roger Dumoulin-White
https://www.youtube.com/watch?v=3Zz7CkBRDN8&feature=youtu.be
Dr Kulkarni & Dr Lilge - Theralase AGM 2014
https://www.youtube.com/watch?v=78rigjdgZSk&feature=youtu.be
Roger Dumoulin-White, President and CEO, Theralase stated that, "Theralase has made significant strides forward in 2015 in both the commercialization of its next generation TLC-2000 therapeutic laser system and its TLC-3000 anti-cancer technology focused on the destruction of Non-Muscle Invasive Bladder Cancer. The TLC-2000 is on track to launch in Canada in 4Q2015, while the TLC-3000 is also on track to commence enrolling patients in late 4Q2015. 4Q2015 will prove to be a significant quarter for the completion of milestones in the history of Theralase."
About Theralase Technologies Inc.